Interleukin-23 Antagonist [EPC]
4 drugs in this class with 246,063 total adverse event reports.
4 Drugs
246,063 Total Reports
158,035 Serious Reports
9,345 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Ustekinumab | USTEKINUMAB | 100,109 | 41,676 | 5,688 |
| 2 | Risankizumab-Rzaa | RISANKIZUMAB-RZAA | 76,587 | 71,946 | 2,682 |
| 3 | Ixekizumab | IXEKIZUMAB | 36,303 | 19,206 | 539 |
| 4 | Guselkumab | GUSELKUMAB | 33,064 | 25,207 | 436 |